There were only 4 new shares in the US stock market last week , biotechnology company Castellum $CTM fell sharply on the first day of transfer to the motherboard, 55% decline ； Spring Valley $SVIIU and Tenx Keane $TENKU, the two blank check companies, increased by 1% and 0.3% respectively in the initial listing; Hudson $HUDAU, the national security information company, rose 0.01% on the first day.

This week's IPO market, so far, It is temporarily expected that 5 new shares will be listed Prime Medicine, the gene editing company with the highest financing amount, is expected to be listed on Thursday. It should be noted that the IPO time of US stocks may change from time to time (including advance and delay), and investors need to continue to follow up relevant information.

(Data map)

[Express delivery of highlights of new shares]

1、 Intensity Therapeutics,Inc.

Introduction: Intensity Therapeutics, Inc. $INTS, founded in 2012, headquartered in Westport, Connecticut, with 15 full-time employees, is a biotechnology company at the clinical stage, committed to applying scientific leadership in the field of local cancer reduction to achieve anti-cancer immune activation.

Fund raising: Intensity Therapeutics plans to 2.2 million yuan issued at a price of 4 to 5 dollars Shares. At the midpoint of the proposed range, the market value of Intensity Therapeutics will reach $183 million. A. G.P. and Brookline Capital Markets are the joint bookrunners of the transaction.

2、Alopexx, Inc.

Introduction: Alopexx, Inc. $ALPX, founded in 2006, is headquartered in Cambridge, Massachusetts, United States, with three full-time employees. Alopexx is a biotechnology company in the clinical stage, which develops new immunotherapy for the prevention, treatment and alleviation of bacterial, fungal and parasitic infections. These infections express antigenic targets poly N-acetylglucosamine (PNAG).

Fund raising: Alopexx Inc. plans to Issue 3 million yuan at a price of 5 dollars Shares to raise $15 million.

3、 Aspire Real Estate Investors,Inc.

Introduction: Aspire Real Estate Investors, Inc., a newly established company in Maryland, is mainly engaged in investment, development, redevelopment and management of major affordable multi family properties in metropolitan areas of the United States. The company is mainly composed of affordable labor force and family property. The company is externally managed and consulted by the newly established entity of Aspire REIT Manager, LLC.

Fund raising: Aspire Real Estate Investors plans to $5 to $7 to issue 2 million Shares.

4、Prime Medicine Inc.

Introduction: Prime Medicine Inc., founded in 2019 and headquartered in Cambridge, Massachusetts, USA, with 137 full-time employees, is a biotechnology company dedicated to providing a new type of differential one-time therapeutic gene therapy Prime Editors, which solves the widest range of diseases by deploying Prime Editing technology, Prime Medicine believes that this is a multi-functional, accurate, efficient and extensive gene editing technology.

Fund raising: Prime Medicine announced plans to adopt 8.9 million issued at a price of $16 to $18 Shares to raise $151 million. At the midpoint of the proposed range, Prime Medicine will gain a fully diluted market value of $1.7 billion.

5、Beamr Imaging

Introduction: Beamr Imaging $BMR was founded in 2009, headquartered in Herzeliya, Israel, with 29 full-time employees. Beamr Imaging is an innovator of video coding, transcoding and optimization solutions, which can provide high-quality, high-performance and unparalleled bit rate efficiency for video and images.

Fund raising: Beamr Imaging plans to Issue 3 million yuan at a price of 5 dollars Shares to raise $15 million.

These are the five new shares expected to be listed and traded this week. Recent news worthy of attention include:

In terms of Chinese concept stocks, Mao Shi Jade Jewelry International Investment Ltd., from Mao Shi Jade, plans to be listed on NASDAQ in the United States, with the code of "MSFC"; Yaduo Group and other companies update the prospectus.